JP2023542209A5 - - Google Patents

Info

Publication number
JP2023542209A5
JP2023542209A5 JP2023518383A JP2023518383A JP2023542209A5 JP 2023542209 A5 JP2023542209 A5 JP 2023542209A5 JP 2023518383 A JP2023518383 A JP 2023518383A JP 2023518383 A JP2023518383 A JP 2023518383A JP 2023542209 A5 JP2023542209 A5 JP 2023542209A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
antibody
antibody fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023518383A
Other languages
English (en)
Japanese (ja)
Other versions
JP7851303B2 (ja
JP2023542209A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/076052 external-priority patent/WO2022063819A1/en
Publication of JP2023542209A publication Critical patent/JP2023542209A/ja
Publication of JP2023542209A5 publication Critical patent/JP2023542209A5/ja
Application granted granted Critical
Publication of JP7851303B2 publication Critical patent/JP7851303B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023518383A 2020-09-24 2021-09-22 ヒトcd3イプシロンに結合する新規なヒト抗体 Active JP7851303B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20197975 2020-09-24
EP20197975.4 2020-09-24
PCT/EP2021/076052 WO2022063819A1 (en) 2020-09-24 2021-09-22 Novel human antibodies binding to human cd3 epsilon

Publications (3)

Publication Number Publication Date
JP2023542209A JP2023542209A (ja) 2023-10-05
JP2023542209A5 true JP2023542209A5 (cg-RX-API-DMAC7.html) 2024-09-24
JP7851303B2 JP7851303B2 (ja) 2026-04-24

Family

ID=72644112

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023518383A Active JP7851303B2 (ja) 2020-09-24 2021-09-22 ヒトcd3イプシロンに結合する新規なヒト抗体

Country Status (9)

Country Link
US (1) US20230357398A1 (cg-RX-API-DMAC7.html)
EP (1) EP4217391A1 (cg-RX-API-DMAC7.html)
JP (1) JP7851303B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230074192A (cg-RX-API-DMAC7.html)
CN (1) CN116209680A (cg-RX-API-DMAC7.html)
AU (1) AU2021350342A1 (cg-RX-API-DMAC7.html)
CA (1) CA3189473A1 (cg-RX-API-DMAC7.html)
IL (1) IL301276A (cg-RX-API-DMAC7.html)
WO (1) WO2022063819A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022318255A1 (en) 2021-07-27 2024-01-18 Morphosys Ag Combinations of antigen binding molecules
JP2026502768A (ja) * 2022-10-25 2026-01-27 アブレクシス, エルエルシー 抗cd3抗体
WO2025003511A1 (en) 2023-06-30 2025-01-02 Morphosys Ag Dual-targeting of flt3 and cd123 co-expressing tumor cells by functional complementation of cycat® halfbody molecules
WO2025036892A1 (en) 2023-08-14 2025-02-20 Morphosys Ag Cycat halfbody molecules comprising sterically occluding moieties
WO2025082777A1 (en) 2023-10-17 2025-04-24 Morphosys Ag Dual-targeting of muc16 and mesothelin co-expressing tumor cells by functional complementation of cycat® halfbody molecules
WO2026161387A1 (en) * 2025-01-21 2026-07-30 Bristol-Myers Squibb Company Cd3 binding molecules and related methods and uses

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
JP3614866B2 (ja) 1997-06-12 2005-01-26 リサーチ コーポレイション テクノロジーズ,インコーポレイティド 人工抗体ポリペプチド
US6136599A (en) 1998-12-10 2000-10-24 Bayer Corporation Human hybrid host cell for mammalian gene expression
CA2347973C (en) 1999-07-20 2010-06-22 Morphosys Ag Novel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
WO2008119567A2 (en) 2007-04-03 2008-10-09 Micromet Ag Cross-species-specific cd3-epsilon binding domain
EP2640742B1 (en) 2010-11-19 2018-08-15 MorphoSys AG A collection of antibody sequences its use
MX359411B (es) 2012-01-13 2018-09-27 Univ Wuerzburg J Maximilians Complementación funcional bipartita inducida por antígenos, dual.
CN106459201A (zh) * 2014-05-28 2017-02-22 豪夫迈·罗氏有限公司 结合人和食蟹猴CD3ε的抗体
US11472880B2 (en) 2017-08-14 2022-10-18 Morphosys Ag Humanized antibodies for CD3
CA3121699A1 (en) 2018-12-05 2020-06-11 Morphosys Ag Multispecific antigen-binding molecules

Similar Documents

Publication Publication Date Title
CN110431231B (zh) 抗-cd3抗体和包含所述抗体的分子
CN111484555B (zh) 新型双特异性cd3/cd20多肽复合物
EP3668898A1 (en) Humanized antibodies for cd3
JP2022533538A5 (cg-RX-API-DMAC7.html)
RU2020130795A (ru) Нейтрализующие антитела к env вич-1 и их применение
JP7851303B2 (ja) ヒトcd3イプシロンに結合する新規なヒト抗体
JP2020515277A5 (cg-RX-API-DMAC7.html)
JP7679399B2 (ja) 抗flt3抗体及び組成物
JP7830445B2 (ja) インターロイキン1アルファに特異的な真のヒト抗体
JP2024540148A5 (cg-RX-API-DMAC7.html)
JP2023510982A5 (cg-RX-API-DMAC7.html)
WO2023186081A1 (zh) 抗tigit-抗pvrig双特异性抗体、其药物组合物及用途
JP2022553908A5 (cg-RX-API-DMAC7.html)
JP2021512652A5 (cg-RX-API-DMAC7.html)
JP2024516098A5 (cg-RX-API-DMAC7.html)
WO2022073102A1 (en) TRUE HUMAN ANTIBODY SPECIFIC FOR INTERLEUKIN 1 ALPHA (IL-1α)
WO2023186063A1 (zh) 抗pvrig抗体、其药物组合物及用途
JP2023545007A (ja) インターロイキン1アルファに特異的な真のヒト抗体
JP2023545005A (ja) インターロイキン1アルファに特異的な真のヒト抗体
JP2025513714A5 (cg-RX-API-DMAC7.html)
JP2024522075A5 (cg-RX-API-DMAC7.html)
JP2024519078A5 (cg-RX-API-DMAC7.html)
IL277899B2 (en) Methods and preparations for treating yellow fever
JP2024516621A5 (cg-RX-API-DMAC7.html)
EA053064B1 (ru) Антитела к дектину-1 и способы их применения